Palo Alto Networks Medical Device Security is a commercial medical device security solution by Palo Alto Networks. Tripwire IP360 is a commercial vulnerability assessment solution by Tripwire. Features, integrations, deployment and the company behind each one, side by side.
What our shortlists say about the one we picked.
Best for: Hospitals that need device visibility and policy enforcement on the Palo Alto network
It fits mid-market and enterprise and is hybrid-deployable. The case is strongest for healthcare organizations already running Palo Alto Networks firewalls, where the policy enforcement is native.
From Best OT Security Solutions for Business, Fall 2026
Reviewed by Nika (Nikoloz) Kokhreidze.
Secures medical devices with visibility, risk assessment, and policy enforcement
Vulnerability management solution for network asset discovery
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
Tripwire IP360 fits if you are a small business.
Common questions when comparing Palo Alto Networks Medical Device Security vs Tripwire IP360 for medical device security.
Palo Alto Networks Medical Device Security: Secures medical devices with visibility, risk assessment, and policy enforcement. Built by Palo Alto Networks.
Tripwire IP360: Vulnerability management solution for network asset discovery. Built by Tripwire.
The table above shows where their features, integrations, deployment and company size fit differ.
Palo Alto Networks Medical Device Security is made by Palo Alto Networks. Tripwire IP360 is made by Tripwire. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
In part. Palo Alto Networks Medical Device Security and Tripwire IP360 are not in the same category on CybersecTools. Use the table above to see where features, deployment and company size fit differ.
No Medical Device Security shortlist yet. This is the closest one.
Updated 2026-11-02
See the shortlist
